{"data":{"id":"us/42-cfr-414.806","jurisdiction":"us","citation":"42 CFR 414.806","heading":"Penalties associated with misrepresentation and the failure to submit timely and accurate ASP data.","body":"(a) Misrepresentation. Section 1847A(d)(4)(A) of the Act specifies the penalties associated with misrepresentations in the reporting of the manufacturer's average sales price for a drug as defined at § 414.802.\n(b) Failure to provide timely information or the submission of false information. (1) For a manufacturer that has entered into and has in effect a rebate agreement under section 1927 of the Act, section 1927(b)(3)(C) of the Act specifies the penalties associated with a manufacturer's failure to submit timely information or the submission of false information.\n(2) For a manufacturer that has not entered into and does not have in effect a rebate agreement under section 1927 of the Act, sections 1847A(d)(4)(B) and (C) of the Act specify the penalties associated with a manufacturer's failure to submit timely information or the submission of false information.","path":["Title 42—Public Health","CHAPTER IV—CENTERS FOR MEDICARE \u0026 MEDICAID SERVICES, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER B—MEDICARE PROGRAM","PART 414—PAYMENT FOR PART B MEDICAL AND OTHER HEALTH SERVICES","Subpart J—Submission of Manufacturer's Average Sales Price Data"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-42.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:26:11Z","sha256":"4d99997365f0c60f1ef53c42782830ac8795d2f593f03115f1d7c95e31d99121","source_id":"us-cfr","stale":true,"prev":"us/42-cfr-414.804","next":"us/42-cfr-414.900"},"notice":"GroundRules: Original legal text. Not legal advice."}